Cyril Robil

884 total citations
7 papers, 55 citations indexed

About

Cyril Robil is a scholar working on Infectious Diseases, Molecular Biology and Physiology. According to data from OpenAlex, Cyril Robil has authored 7 papers receiving a total of 55 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 3 papers in Molecular Biology and 3 papers in Physiology. Recurrent topics in Cyril Robil's work include COVID-19 Clinical Research Studies (2 papers), Gut microbiota and health (2 papers) and Diet and metabolism studies (2 papers). Cyril Robil is often cited by papers focused on COVID-19 Clinical Research Studies (2 papers), Gut microbiota and health (2 papers) and Diet and metabolism studies (2 papers). Cyril Robil collaborates with scholars based in France, Australia and Niger. Cyril Robil's co-authors include François Trottein, Valentin Sencio, Séverine Heumel, Lucie Deruyter, Corinne Grangette, Harry Sokol, François Briand, Arnaud Machelart, Isabelle Wolowczuk and Thierry Sulpice and has published in prestigious journals such as Scientific Reports, Frontiers in Immunology and Frontiers in Microbiology.

In The Last Decade

Cyril Robil

5 papers receiving 54 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cyril Robil France	4	33	27	10	9	9	7	55
Shanshan Fu China	3	15 0.5×	33 1.2×	5 0.5×	8 0.9×	5 0.6×	11	70
Alessandra Guarnaccia Italy	3	28 0.8×	53 2.0×	4 0.4×	4 0.4×	12 1.3×	4	74
Laura B. Cantwell United States	4	23 0.7×	20 0.7×	10 1.0×	6 0.7×	9 1.0×	4	57
Haihong Zhao China	5	28 0.8×	15 0.6×	4 0.4×	16 1.8×	12 1.3×	8	72
Haley B. Williams United States	4	54 1.6×	47 1.7×	3 0.3×	11 1.2×	10 1.1×	9	84
Christine M. Bradshaw United States	6	21 0.6×	15 0.6×	2 0.2×	4 0.4×	15 1.7×	10	74
Paloma Cal‐Sabater Spain	3	24 0.7×	5 0.2×	4 0.4×	13 1.4×	9 1.0×	4	51
Ru Bai China	3	35 1.1×	4 0.1×	5 0.5×	6 0.7×	2 0.2×	5	52
Elisa Docampo Martínez Belgium	3	32 1.0×	37 1.4×	5 0.5×		4 0.4×	4	49

Countries citing papers authored by Cyril Robil

Since Specialization

Citations

This map shows the geographic impact of Cyril Robil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cyril Robil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cyril Robil more than expected).

Fields of papers citing papers by Cyril Robil

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cyril Robil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cyril Robil. The network helps show where Cyril Robil may publish in the future.

Co-authorship network of co-authors of Cyril Robil

This figure shows the co-authorship network connecting the top 25 collaborators of Cyril Robil. A scholar is included among the top collaborators of Cyril Robil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cyril Robil. Cyril Robil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Sencio, Valentin, Jonathan Chatagnon, Janelle M. Fine, et al.. (2025). Pulmonary delivery of clofoctol-loaded nanoparticles inhibits SARS-CoV-2 replication and reduces pneumonia. International Journal of Pharmaceutics. 677. 125634–125634.

2.

Makki, Kassem, Patrícia Brito Rodrigues, Olivier Molendi‐Coste, et al.. (2025). Impact of aging on gut-lung-adipose tissue interactions and lipid metabolism during influenza infection in mice. Scientific Reports. 15(1). 37414–37414.

3.

Heumel, Séverine, Lucie Deruyter, Véronique Robert, et al.. (2024). Faecalibacterium duncaniae as a novel next generation probiotic against influenza. Frontiers in Immunology. 15. 1347676–1347676. 19 indexed citations

4.

Rivière, Céline, Lowiese Desmarets, Cyril Robil, et al.. (2024). Hyperforin, the major metabolite of St. John’s wort, exhibits pan-coronavirus antiviral activity. Frontiers in Microbiology. 15. 1443183–1443183. 1 indexed citations

5.

Sencio, Valentin, Patrícia Brito Rodrigues, Karin Séron, et al.. (2023). SARS-CoV-2 infection induces persistent adipose tissue damage in aged golden Syrian hamsters. Cell Death and Disease. 14(2). 75–75. 9 indexed citations

6.

Briand, François, Valentin Sencio, Cyril Robil, et al.. (2022). Diet-Induced Obesity and NASH Impair Disease Recovery in SARS-CoV-2-Infected Golden Hamsters. Viruses. 14(9). 2067–2067. 10 indexed citations

7.

Sencio, Valentin, Nicolas Benech, Cyril Robil, et al.. (2022). Alteration of the gut microbiota’s composition and metabolic output correlates with COVID-19-like severity in obese NASH hamsters. Gut Microbes. 14(1). 2100200–2100200. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact